Clinical Trial Update: Tislelizumab Combined With Pemetrexed/ Carboplatin in Patients With Brain Metastases of Non-squamous NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tislelizumab in combination with pemetrexed and carboplatin for brain metastases in non-squamous non-small cell lung cancer has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Pemetrexed (pemetrexed)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: NSCLC Stage IV, Brain Metastases | Phase 2 | Status: COMPLETED